Grant by Novartis Sample Clauses

The "Grant by Novartis" clause defines the rights or licenses that Novartis is providing to the other party under the agreement. Typically, this clause specifies the scope of the intellectual property, technology, or other assets being granted, including any limitations on use, territory, or duration. For example, Novartis may grant a license to use a patented drug compound for research or commercialization in certain countries. The core function of this clause is to clearly delineate what rights are being transferred or permitted, thereby preventing misunderstandings and ensuring both parties know the extent of their rights and obligations.
Grant by Novartis. Novartis hereby grants to Rigel and its Affiliates a nonexclusive, non-transferable, royalty-free license during the Research Period for each Collaboration Project under the Novartis Technology and Novartis' interest in the Project Technology, subject to the terms of this Agreement, solely for the purpose of carrying out Rigel's responsibilities under the applicable Collaboration Project.
View SourceView Similar (4)
Grant by Novartis. Novartis hereby grants to Versicor and its Affiliates a worldwide, nonexclusive, non-transferable, royalty-free research license during the Research Program Term under Novartis' interest in Patent Rights of Novartis, Joint Patent Rights, Research Compounds and Know-How of Novartis, subject to the terms of this Agreement, solely for the purpose of carrying out Versicor's responsibilities under the Research Program.
View SourceView Similar (2)
Grant by Novartis. Subject to the terms and conditions of this Agreement, Novartis hereby grants to Celgene and its Affiliates an exclusive, fully-paid license in the Territory, with the right to sublicense, under Novartis Patent Rights, Novartis' interest in Joint Patent Rights and Know-How of Novartis to develop, make, have made, use, sell, offer for sale and import: (i) pharmaceutical products containing Research Compounds and Active Compounds selected by Celgene from the Oncology Pool pursuant to Section 5.2 in the Oncology Field; and (ii) Celgene Products in each Additional Field to which Celgene obtains rights under Section 5.4.
View Source
Grant by Novartis. Subject to the terms and conditions of this Agreement, Novartis hereby grants to Celgene and its Affiliates a worldwide, non-exclusive non-transferable, royalty-free research license during the Research Term under Novartis Patent Rights, Novartis' interest in Joint Patent Rights and Know-How of Novartis solely for the purpose of carrying out Celgene's responsibilities under the Research Program.
View Source
Grant by Novartis 
View SourceView Similar (19)

Related to Grant by Novartis

  • Assignment by Executive This Agreement shall inure to the benefit of and be enforceable by the Executive's executor and/or administrators, heirs, devisees, and legatees. If the Executive should die while any amount would be payable to Executive hereunder had the Executive continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to the Executive's estate. Executive's rights hereunder shall not otherwise be assignable.

  • Acknowledgment by Executive The Executive acknowledges and confirms that (a) the restrictive covenants contained in this Article 6 are reasonably necessary to protect the legitimate business interests of the Company, and (b) the restrictions contained in this Article 6 (including without limitation the length of the term of the provisions of this Article 6) are not overbroad, overlong, or unfair and are not the result of overreaching, duress or coercion of any kind. The Executive further acknowledges and confirms that his full, uninhibited and faithful observance of each of the covenants contained in this Article 6 will not cause him any undue hardship, financial or otherwise, and that enforcement of each of the covenants contained herein will not impair his ability to obtain employment commensurate with his abilities and on terms fully acceptable to him or otherwise to obtain income required for the comfortable support of him and his family and the satisfaction of the needs of his creditors. The Executive acknowledges and confirms that his special knowledge of the business of the Company is such as would cause the Company serious injury or loss if he were to use such ability and knowledge to the benefit of a competitor or were to compete with the Company in violation of the terms of this Article 6. The Executive further acknowledges that the restrictions contained in this Article 6 are intended to be, and shall be, for the benefit of and shall be enforceable by, the Company’s successors and assigns.

  • Management by Members Management of the Company shall be vested in its members. The members shall have the exclusive right, power and authority to manage and operate the business and affairs of the Company and to authorize any act or transaction on behalf of the Company. The members may from time to time appoint and delegate authority to act on behalf of the Company to such officers as the members deem appropriate. Any deed, agreement or other instrument, whether or not for apparently carrying on in the usual way the business or affairs of the Company, shall be binding on the Company and may be relied upon by any person or entity which is supplied with such executed deed, agreement or other instrument, if the same is executed on behalf of the Company by a member.

  • No Assignment by Executive Executive warrants and represents that no portion of any of the matters released herein, and no portion of any recovery or settlement to which Executive might be entitled, has been assigned or transferred to any other person, firm or corporation not a party to this Agreement, in any manner, including by way of subrogation or operation of law or otherwise. If any claim, action, demand or suit should be made or instituted against the Company or any other Releasee because of any actual assignment, subrogation or transfer by Executive, Executive agrees to indemnify and hold harmless the Company and all other Releasees against such claim, action, suit or demand, including necessary expenses of investigation, attorneys’ fees and costs. In the event of Executive’s death, this Agreement shall inure to the benefit of Executive and Executive’s executors, administrators, heirs, distributees, devisees, and legatees. None of Executive’s rights or obligations may be assigned or transferred by Executive, other than Executive’s rights to payments hereunder, which may be transferred only upon Executive’s death by will or operation of law.

  • Delivery of Materials upon Termination of Employment As requested by the Company from time to time and upon the termination of Executive's employment with the Company for any reason, Executive shall promptly deliver to the Company all copies and embodiments, in whatever form, of all Confidential Information and Intellectual Property in Executive's possession or within his control (including, but not limited to, written records, notes, photographs, manuals, notebooks, documentation, program listings, flow charts, magnetic media, disks, diskettes, tapes and all other materials containing any Confidential Information or Intellectual Property) irrespective of the location or form of such material and, if requested by the Company, shall provide the Company with written confirmation that all such materials have been delivered to the Company.